Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-09-26

Clinical Trial Update: Epidural Morphine for Analgesia After Traumatic Vaginal Delivery [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating epidural morphine for analgesia after traumatic vaginal delivery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • epidural morphine (morphine)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Traumatic Vaginal Delivery | Phase 4 | Status: WITHDRAWN